Solar Nuclear, a Melbourne, Fla-based Mirion Medical firm, acquired Oncospace, an organization offering cloud-based, AI-powered options for the radiation oncology neighborhood.
The quantity of the deal was not disclosed.
Oncospace options might be built-in into Solar Nuclear Model, increasing radiation remedy high quality assurance digital-forward technique.
Oncospace’s AI and machine-learning applied sciences are designed to develop data-driven, physician-centric options that optimize affected person outcomes. Since its inception in 2018, Oncospace has launched two most important choices:
- Gateway: A Therapy Planning Conversion resolution for Philips Pinnacle customers, which converts affected person archives to fashionable therapy planning options, reminiscent of Raysearch Raystation and Varian Medical Programs® Eclipse. Whereas initially developed for prostate remedies, this resolution has since expanded to go and neck radiotherapy, with future choices deliberate.
- A Predictive Plan High quality and Feasibility resolution, which leverages the AI method of machine studying to investigate 1000’s of scientific therapy plans and derive achievable, best-practice dosimetry targets for plan optimization and analysis.
“We’re excited to welcome Oncospace into the Solar Nuclear household,” mentioned
Led by Luis Rivera, president, Solar Nuclear is a part of Mirion Medical, a gaggle of healthcare-focused manufacturers inside Mirion, offering progressive options for Radiation Remedy and Diagnostic Imaging facilities. Greater than 6,000 most cancers facilities worldwide use Solar Nuclear for impartial, built-in High quality Administration. By informing actions via harnessing very important info, the Oncospace choices handle the calls for of radiation oncology professionals whereas bettering the precision and effectivity of radiation remedy planning, thus enhancing the general high quality of care and outcomes.
FinSMEs
30/04/2025
